Similar articles

• [Intensive glycemia control of type-2 diabetes mellitus: a real A(D)VANCe or a deep dis(ACCORD)?].

  Lambiel J, Fumeaux T. Lambiel J, et al. Rev Med Suisse. 2008 Aug 6;4(166):1734. Rev Med Suisse. 2008. PMID: 18777740 French. No abstract available.
• [Intensive glucose control in type 2 diabetes is beneficial].

  Nilsson PM, Attvall S. Nilsson PM, et al. Lakartidningen. 2009 Sep 2-8;106(36):2198. Lakartidningen. 2009. PMID: 19817174 Swedish. No abstract available.
• Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial.

  Ismail-Beigi F, Craven T, Banerji MA, Basile J, Calles J, Cohen RM, Cuddihy R, Cushman WC, Genuth S, Grimm RH Jr, Hamilton BP, Hoogwerf B, Karl D, Katz L, Krikorian A, O'Connor P, Pop-Busui R, Schubart U, Simmons D, Taylor H, Thomas A, Weiss D, Hramiak I; ACCORD trial group. Ismail-Beigi F, et al. Lancet. 2010 Aug 7;376(9739):419-30. doi: 10.1016/S0140-6736(10)60576-4. Epub 2010 Jun 30. Lancet. 2010. PMID: 20594588 Free PMC article. Clinical Trial.
• Postprandial hyperglycaemia--its importance and implications.

  Lüddeke HJ. Lüddeke HJ. Int J Clin Pract Suppl. 1999 Jul;104:3-7; discussion 18-20. Int J Clin Pract Suppl. 1999. PMID: 12669731 Review. No abstract available.
• Effects of glucose-lowering agents on vascular outcomes in type 2 diabetes: a critical reappraisal.

  Scheen AJ, Charbonnel B. Scheen AJ, et al. Diabetes Metab. 2014 Jun;40(3):176-85. doi: 10.1016/j.diabet.2014.03.004. Epub 2014 Apr 30. Diabetes Metab. 2014. PMID: 24792220 Review.